Spire Healthcare Group (LSE:SPI) 3-Year EPS without NRI Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Spire Healthcare Group 3-Year EPS without NRI Growth Rate?

Spire Healthcare Group's EPS without NRI for the six months ended in Dec. 2023 was £0.04.

During the past 12 months, Spire Healthcare Group's average EPS without NRI Growth Rate was 87.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Spire Healthcare Group was 19.50% per year. The lowest was -49.90% per year. And the median was -11.20% per year.

Competitive Comparison of Spire Healthcare Group's 3-Year EPS without NRI Growth Rate

For the Medical Care Facilities subindustry, Spire Healthcare Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spire Healthcare Group's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Spire Healthcare Group's 3-Year EPS without NRI Growth Rate falls into.

Spire Healthcare Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Spire Healthcare Group (LSE:SPI) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Spire Healthcare Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Spire Healthcare Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Spire Healthcare Group (LSE:SPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Spire Healthcare Group PLC (LSE:SPI) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

SPIl:UK S00:Germany

Address

3 Dorset Rise, London, GBR, EC4Y 8EN

Website

https://www.spirehealthcare.com

Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.